Sensitivity and Resistivity of Various Antibiotics Against of Pseudomonas aeruginosa in Clinical Isolates: Antibiotics Against Clinical Isolates of Pseudomonas aeruginosa

Ansar Abbas; Lahraseb Khan; Hafiz Shehzad Muzammil; Muhammad Mohsin Aftab

doi:10.54393/fbt.v1i01.7

Authors

Ansar Abbas Virtual University, Lahore, Pakistan
Lahraseb Khan Institute of Molecular Biology and Biotechnology, University of Lahore, Pakistan
Hafiz Shehzad Muzammil National Institute of Food Science and Technology, University of Agriculture, Faisalabad, Pakistan
Muhammad Mohsin Aftab Institute of Public Health, Lahore, Pakistan

DOI:

https://doi.org/10.54393/fbt.v1i01.7

Keywords:

Antibiotics, Gram Negative Bacteria, Diseases, Patients

Abstract

Antibiotics are an essential therapy for a variety of bacterial infections, but misuse and overuse of them is encouraging bacterial resistance. Objective: To check different drugs' antibacterial effects on Pseudomonas aeruginosa was the goal. Methods: For this experiment, samples were taken from patients in the pathology division of the Fatima Memorial Hospital in Lahore, Pakistan. From all of the samples gathered, 170 clinical isolates of P. aeruginosa were discovered. To identify bacteria, traditional culture and biochemical techniques were performed. Antibacterial activity was determined by comparing the antibiotic susceptibility patterns of all clinical isolates to commercial antibiotic discs (cefazolin, cefepime, cefixime, cefoxitin, ceftriaxone, ceftazidime, cefuroxime, cephalothin, amikacin, amoxycillin, ampicillin, Augmentin, ciprofloxacin, clindamycin, gentamycin, imipenem. Results: Imipenem (100% sensitivity), Ceftazidime (99%), Linezolid (99%), Clindamycin (99%), Gentamycin (92%), Ciprofloxacin (88%), Levofloxacin (78%), and Cefotaxime (71%), among other antibiotics, shown remarkable sensitivity against Pseudomonas aeruginosa. Conclusions: We came to the conclusion that all clinical isolates of P. aeruginosa exhibited broad resistance to meropenem, ampicillin, cefuroxime, and cefepime. To reduce antibiotic resistance, technical infrastructure must be improved. Appropriate antibiotic selection and advised hand washing are two such measures.

References

Hasan B, Perveen K, Olsen B, Zahra R. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. Journal of Medical Microbiology. 2014 Jan; 63(1): 50-5. doi: 10.1099/jmm.0.063925-0

Gould IM and Bal AM. New antibiotic agents in the pipeline and how they can help overcome microbial resistance. Virulence. 2013 Feb; 4(2): 185-91. doi: 10.4161/viru.22507

Iredell J, Brown J, Tagg K. Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications. Bmj. 2016 Feb; 352. doi: 10.1136/bmj.h6420

Haq FU, Imran M, Saleem S, Aftab U, Ghazal A. Investigation of Morchella esculenta and Morchella conica for their antibacterial potential against methicillin-susceptible Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Streptococcus pyogenes. Archives of Microbiology. 2022 July; 204(7): 1-13. doi: 10.1007/s00203-022-03003-8

Arnott A, Wang Q, Bachmann N, Sadsad R, Biswas C, Sotomayor C, et al. Multidrug-Resistant Salmonella enterica 4,[5], 12: i: -Sequence Type 34, New South Wales, Australia, 2016-2017. Emerging Infectious Diseases. 2018 Apr; 24(4): 751-53. doi: 10.3201/eid2404.171619

Kaleem F, Usman J, Hassan A, Omair M, Khalid A, Uddin R. Sensitivity pattern of methicillin resistant Staphylococcus aureus isolatedfrom patients admitted in a tertiary care hospital of Pakistan. Iranian Journal of Microbiology. 2010; 2(3): 141-3.

Walsh TR. Emerging carbapenemases: a global perspective. International journal of antimicrobial agents. 2010 Nov; 36: S8-14. doi: 10.1016/S0924-8579(10)70004-2

Klemm EJ, Shakoor S, Page AJ, Qamar FN, Judge K, Saeed DK, et al. Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. MBio. 2018 Mar; 9(1): e00105-18. doi: 10.1128/mBio.00105-18

Siegel RE. Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences. Respiratory Care. 2008 Apr; 53(4): 471-9.

Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrobial Agents and Chemotherapy. 2008 Mar; 52(3): 813-21. doi: 10.1128/AAC.01169-07

Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. The American Journal of Clinical Nutrition. 2001 Dec; 74(6): 833-9. doi: 10.1093/ajcn/74.6.833

Slama TG. Gram-negative antibiotic resistance: there is a price to pay. Critical Care. 2008 May; 12: 1-7. doi: 10.1186/cc6817

Chopra I, Schofield C, Everett M, O'Neill A, Miller K, Wilcox M, et al. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. The Lancet Infectious Diseases. 2008 Feb; 8(2): 133-9. doi: 10.1016/S1473-3099(08)70018-5

Antonio MA, Hawes SE, Hillier SL. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. Journal of Infectious Diseases. 1999 Dec; 180(6): 1950-6. doi: 10.1086/315109

Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Reviews of Infectious Diseases. 1990 Sep; 12(5): 856-72. doi: 10.1093/clinids/12.5.856

Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiology Reviews. 2004 Oct; 28(4): 405-40. doi: https://doi.org/10.1016/j.femsre.2004.01.003

McFarland LV. Normal flora: diversity and functions. Microbial Ecology in Health and Disease. 2000 Jan; 12(4): 193-207. doi: 10.1080/08910600050216183

Reid G and Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes and infection. 2002 Mar; 4(3): 319-24. doi: 10.1016/S1286-4579(02)01544-7

Fluit A, Verhoef J, Schmitz F, Sentry Participants TE. Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998. European Journal of Clinical Microbiology and Infectious Diseases. 2001 Sep; 20: 617-25. doi: 10.1007/s100960100564

Barakoti A, Guragain A, Adhikari RP, Amatya R. Profile and antimicrobial susceptibility pattern of aerobic bacterial isolates from pus/wound swab samples in a tertiary care hospital, Kathmandu. Nepal Medical College Journal. 2017 Jan; 19(4): 179-83.